Matthew David Miller, MD
Orthopedic Surgery · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 15
- 3 carriers
- Office
- 1
Offices
1 location · El Camino Health Medical Network LLC · 202 clinicians in this group
Hospitals listed: 057007 · 059237 · El Camino Health · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
15 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Miller’s office at (408) 871-3400 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A93546 · Current
Licensed to practise in California · since 2005 · expires 2027-10-31 · Boston University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Illinois 036123296Licensed Physician And Surgeon · since 2009 · expires 2011-07-31Not RenewedNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$427,068
Medicare paid this office $427,068 for 601 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Replacement of knee joint, both sides of knee | 133 | $170,195 | $1,166 |
| Replacement of thigh bone and hip joint with prosthesis | 49 | $58,518 | $1,170 |
| Musculoskeletal surgical navigational orthopedic operation using imaging guidance | 164 | $33,046 | $186 |
| Revision of thigh and lower leg bone components of total knee joint prosthesis | 15 | $24,992 | $1,562 |
| New patient visit (45+ min) | 148 | $22,943 | $155 |
See all 13 services
| Replacement of knee joint, both sides of knee | 133 | $170,195 | $1,166 |
| Replacement of thigh bone and hip joint with prosthesis | 49 | $58,518 | $1,170 |
| Musculoskeletal surgical navigational orthopedic operation using imaging guidance | 164 | $33,046 | $186 |
| Revision of thigh and lower leg bone components of total knee joint prosthesis | 15 | $24,992 | $1,562 |
| New patient visit (45+ min) | 148 | $22,943 | $155 |
| Long return visit (40+ min) | 98 | $17,065 | $169 |
| Short return visit (20+ min) | 155 | $15,265 | $85 |
| Replacement of knee joint on side of knee | 12 | $13,715 | $1,055 |
| New patient visit (60+ min) | 52 | $10,740 | $207 |
| Aspiration and/or injection of fluid from large joint | 92 | $7,003 | $67 |
| Return visit (30+ min) | 54 | $6,370 | $114 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 68 | $4,150 | $53 |
| New patient visit (30+ min) | 33 | $3,227 | $98 |
Procedures Medicare counted
| Hip replacement | 80 | More than 95% of doctors who do this |
| Knee replacement | 188 | More than 98% of doctors who do this |
| Removal of tissue | 1-10 | None |
Who their Medicare patients are
601 Original Medicare patients in 2024. Average age 75 · Under 65 4% · 85 and older 10% · Women 66% · Also on Medicaid 11% · Health risk score 1.03. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 71% · Coronary heart disease 24% · Diabetes 22% · Depression 20% · Atrial fibrillation 18% · Chronic kidney disease 16% · Cancer 16% · Heart failure 11% · COPD 10% · Stroke 7% · Dementia 6%.
The office billed $3,179,616, Medicare allowed $538,936 and paid $427,068; for 1,202 services of 34 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 601 | 1,202 | 75 | 1.03 | $3,179,616 | $427,068 |
| 2023 | 464 | 922 | 74 | 1.03 | $2,740,017 | $333,804 |
| 2022 | 505 | 988 | 75 | 1.00 | $2,866,336 | $341,482 |
| 2021 | 498 | 4,491 | 75 | 1.02 | $3,320,158 | $394,351 |
| 2020 | 456 | 7,775 | 74 | 1.06 | $2,923,026 | $345,019 |
| 2019 | 588 | 6,411 | 74 | 1.05 | $3,207,272 | $362,803 |
| 2018 | 561 | 7,278 | 74 | 1.05 | $3,206,466 | $365,110 |
| 2017 | 566 | 7,002 | 74 | 1.08 | $2,742,147 | $337,060 |
| 2016 | 569 | 4,824 | 74 | 1.08 | $2,313,518 | $303,845 |
| 2015 | 534 | 1,046 | 74 | 1.09 | $2,149,114 | $292,975 |
| 2014 | 400 | 888 | 73 | 1.08 | $1,936,425 | $266,525 |
| 2013 | 298 | 689 | 73 | 1.06 | $1,366,678 | $201,685 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Replacement of knee joint, both sides of knee | 89 | $113,757 | $1,197 |
| Replacement of thigh bone and hip joint with prosthesis | 58 | $71,163 | $1,186 |
| Musculoskeletal surgical navigational orthopedic operation using imaging guidance | 91 | $18,366 | $189 |
| Long return visit (40+ min) | 103 | $18,102 | $172 |
| Short return visit (20+ min) | 136 | $14,778 | $87 |
| New patient visit (45+ min) | 92 | $14,395 | $156 |
| New patient visit (60+ min) | 44 | $9,065 | $206 |
| Aspiration and/or injection of fluid from large joint | 89 | $8,438 | $71 |
| Return visit (30+ min) | 49 | $6,009 | $123 |
| New patient visit (30+ min) | 13 | $1,423 | $109 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 13 | $842 | $53 |
2022: 10 services
| Replacement of knee joint, both sides of knee | 109 | $133,734 | $1,194 |
| Replacement of thigh bone and hip joint with prosthesis | 38 | $44,155 | $1,162 |
| Musculoskeletal surgical navigational orthopedic operation using imaging guidance | 108 | $20,971 | $189 |
| Long return visit (40+ min) | 93 | $16,664 | $172 |
| Short return visit (20+ min) | 139 | $15,138 | $85 |
| New patient visit (45+ min) | 97 | $14,978 | $154 |
| New patient visit (60+ min) | 68 | $13,769 | $202 |
| Return visit (30+ min) | 73 | $8,640 | $115 |
| Aspiration and/or injection of fluid from large joint | 81 | $7,536 | $69 |
| New patient visit (30+ min) | 13 | $1,406 | $108 |
2021: 13 services
| Replacement of knee joint, both sides of knee | 108 | $135,203 | $1,196 |
| Replacement of thigh bone and hip joint with prosthesis | 64 | $82,939 | $1,202 |
| Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | 40 | $27,531 | None |
| Revision of thigh and lower leg bone components of total knee joint prosthesis | 11 | $16,755 | $1,523 |
| New patient visit (60+ min) | 79 | $16,308 | $206 |
| New patient visit (45+ min) | 93 | $13,851 | $149 |
| Return visit (30+ min) | 102 | $12,867 | $118 |
| Short return visit (20+ min) | 119 | $12,442 | $85 |
| Long return visit (40+ min) | 54 | $9,344 | $170 |
| Aspiration and/or injection of fluid from large joint | 84 | $7,970 | $65 |
| Musculoskeletal surgical navigational orthopedic operation using imaging guidance | 39 | $7,448 | $191 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 56 | $3,084 | $48 |
| Injection, ropivacaine hydrochloride, 1 mg | 45 | $87 | None |
2020: 13 services
| Replacement of knee joint, both sides of knee | 76 | $106,514 | $1,253 |
| Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | 70 | $53,875 | None |
| Replacement of thigh bone and hip joint with prosthesis | 39 | $50,814 | $1,270 |
| Revision of thigh and lower leg bone components of total knee joint prosthesis | 11 | $17,780 | $1,616 |
| Short return visit (20+ min) | 196 | $16,594 | $69 |
| New patient visit (30+ min) | 147 | $14,933 | $102 |
| Replacement of knee joint on side of knee | 11 | $12,079 | $1,098 |
| Return visit (30+ min) | 78 | $8,349 | $101 |
| Aspiration and/or injection of fluid from large joint | 93 | $8,323 | $63 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 77 | $4,320 | $53 |
| Telehealth originating site facility fee | 22 | $461 | $21 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 11 | $422 | $38 |
| Injection, ropivacaine hydrochloride, 1 mg | 79 | $186 | None |
2019: 11 services
| Replacement of knee joint, both sides of knee | 98 | $128,556 | $1,224 |
| Replacement of thigh bone and hip joint with prosthesis | 53 | $69,828 | $1,225 |
| Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | 37 | $21,315 | None |
| Short return visit (20+ min) | 246 | $20,345 | $67 |
| New patient visit (30+ min) | 174 | $16,577 | $95 |
| Return visit (30+ min) | 155 | $16,126 | $97 |
| Aspiration and/or injection of fluid from large joint | 111 | $8,633 | $57 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 55 | $2,841 | $50 |
| Therapy procedure using a special bandage and vacuum pump, surface area 50.0 sq cm or less | 18 | $526 | $24 |
| Injection, ropivacaine hydrochloride, 1 mg | 51 | $246 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 23 | $156 | None |
2018: 11 services
| Replacement of knee joint, both sides of knee | 97 | $126,083 | $1,212 |
| Replacement of thigh bone and hip joint with prosthesis | 53 | $63,606 | $1,200 |
| Revision of thigh and lower leg bone components of total knee joint prosthesis | 20 | $31,197 | $1,560 |
| Short return visit (20+ min) | 280 | $23,156 | $63 |
| New patient visit (30+ min) | 174 | $16,549 | $95 |
| Replacement of knee joint on side of knee | 14 | $14,273 | $1,019 |
| Return visit (30+ min) | 100 | $9,458 | $95 |
| Aspiration and/or injection of fluid from large joint | 97 | $7,532 | $58 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 79 | $4,386 | $52 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 84 | $673 | None |
| Injection, ropivacaine hydrochloride, 1 mg | 86 | $373 | None |
2017: 10 services
| Replacement of knee joint, both sides of knee | 103 | $137,820 | $1,220 |
| Replacement of thigh bone and hip joint with prosthesis | 46 | $55,915 | $1,216 |
| Short return visit (20+ min) | 325 | $28,921 | $64 |
| Revision of thigh and lower leg bone components of total knee joint prosthesis | 13 | $19,665 | $1,513 |
| New patient visit (30+ min) | 185 | $17,640 | $95 |
| Aspiration and/or injection of fluid from large joint | 110 | $9,391 | $61 |
| Return visit (30+ min) | 61 | $6,048 | $99 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 21 | $1,955 | $51 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 95 | $893 | None |
| Injection, ropivacaine hydrochloride, 1 mg | 93 | $301 | None |
2016: 10 services
| Replacement of knee joint, both sides of knee | 87 | $112,664 | $1,186 |
| Replacement of thigh bone and hip joint with prosthesis | 52 | $64,609 | $1,196 |
| Short return visit (20+ min) | 323 | $28,266 | $63 |
| New patient visit (30+ min) | 233 | $21,572 | $93 |
| Revision of thigh and lower leg bone components of total knee joint prosthesis | 12 | $18,498 | $1,542 |
| Replacement of knee joint on side of knee | 12 | $13,613 | $1,047 |
| Aspiration and/or injection of fluid from large joint | 87 | $6,365 | $57 |
| Return visit (30+ min) | 44 | $4,179 | $95 |
| Injection, ropivacaine hydrochloride, 1 mg | 26 | $213 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 25 | $139 | None |
2015: 5 services
| Replacement of knee joint, both sides of knee | 73 | $92,577 | $1,251 |
| Replacement of thigh bone and hip joint with prosthesis | 54 | $70,925 | $1,223 |
| Short return visit (20+ min) | 304 | $28,597 | $65 |
| New patient visit (30+ min) | 275 | $25,294 | $92 |
| Aspiration and/or injection of fluid from large joint | 88 | $6,125 | $57 |
2014: 6 services
| Replacement of knee joint, both sides of knee | 72 | $92,319 | $1,199 |
| Replacement of thigh bone and hip joint with prosthesis | 36 | $46,193 | $1,216 |
| Short return visit (20+ min) | 251 | $24,318 | $64 |
| Revision of thigh and lower leg bone components of total knee joint prosthesis | 14 | $21,605 | $1,543 |
| New patient visit (30+ min) | 198 | $18,191 | $92 |
| Aspiration and/or injection of fluid from large joint | 62 | $4,508 | $56 |
2013: 6 services
| Replacement of knee joint, both sides of knee | 46 | $64,558 | $1,345 |
| Replacement of thigh bone and hip joint with prosthesis | 25 | $33,327 | $1,282 |
| Revision of thigh and lower leg bone components of total knee joint prosthesis | 15 | $24,910 | $1,557 |
| Short return visit (20+ min) | 206 | $20,464 | $62 |
| New patient visit (30+ min) | 141 | $12,732 | $90 |
| Aspiration and/or injection of fluid from large joint | 48 | $2,831 | $46 |
Drugs they prescribed that Part D paid
$6,916
Pharmacies billed $6,916 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 20% of their Part D prescriptions (18 of 91) in 2024. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 31%.
87 generic and fewer than 11 brand-name prescriptions · $6,916 in drug cost · 15 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Celecoxib | 19 | $591 | $24 |
Year by year
| 2024 | 91 | 62 | 20% (18) | None | $6,916 |
| 2023 | 155 | 70 | 37% (57) | None | $11,529 |
| 2022 | 95 | 57 | 20% (19) | None | $6,331 |
| 2021 | 95 | 42 | 20% (19) | 20% | $12,098 |
| 2020 | 115 | 57 | 17% (20) | None | $5,407 |
| 2019 | 202 | 87 | 19% (38) | 8% | $17,438 |
| 2018 | 179 | 81 | 23% (41) | 8% | $14,409 |
| 2017 | 217 | 111 | 24% (53) | 13% | $11,665 |
| 2016 | 281 | 134 | 26% (72) | 23% | $18,880 |
| 2015 | 515 | 162 | 17% (85) | 36% | $64,997 |
| 2014 | 640 | 141 | 32% (207) | 40% | $111,136 |
| 2013 | 581 | 131 | 32% (183) | 43% | $92,159 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Celecoxib | 33 | $1,995 | $60 |
| Pregabalin | 17 | $347 | $20 |
| Oxycodone | 34 | $245 | $7 |
| Tramadol | 19 | $81 | $4 |
2022: 2 drugs
| Celecoxib | 20 | $1,295 | $65 |
| Diclofenac | 19 | $288 | $15 |
2021: 1 drug
| Diclofenac | 20 | $456 | $23 |
2020: 2 drugs
| Celecoxib | 16 | $944 | $59 |
| Meloxicam | 16 | $66 | $4 |
2019: 6 drugs
| Celecoxib | 22 | $3,152 | $143 |
| Doxycycline Hyclate | 13 | $2,081 | $160 |
| Gabapentin | 22 | $338 | $15 |
| Oxycodone | 31 | $283 | $9 |
| Meloxicam | 19 | $109 | $6 |
| Amoxicillin | 21 | $89 | $4 |
2018: 6 drugs
| Celecoxib | 17 | $4,030 | $237 |
| Vancomycin | 12 | $1,622 | $135 |
| Oxycodone-Acetaminophen | 18 | $392 | $22 |
| Diclofenac | 12 | $221 | $18 |
| Meloxicam | 18 | $102 | $6 |
| Amoxicillin | 13 | $45 | $3 |
2017: 4 drugs
| Celecoxib | 32 | $3,811 | $119 |
| Oxycodone-Acetaminophen | 29 | $439 | $15 |
| Meloxicam | 25 | $89 | $4 |
| Amoxicillin | 22 | $59 | $3 |
2016: 8 drugs
| Celecoxib | 56 | $6,516 | $116 |
| Lyrica | 14 | $4,127 | $295 |
| Oxaprozin | 30 | $2,623 | $87 |
| Oxycodone-Acetaminophen | 45 | $1,020 | $23 |
| Gabapentin | 15 | $232 | $15 |
| Amoxicillin | 27 | $95 | $4 |
| Meloxicam | 19 | $85 | $4 |
| Tramadol | 11 | $69 | $6 |
2015: 11 drugs
| Celecoxib | 93 | $18,411 | $198 |
| Lyrica | 58 | $16,239 | $280 |
| Xifaxan | 11 | $14,628 | $1,330 |
| Oxaprozin | 36 | $4,381 | $122 |
| Doxycycline Hyclate | 12 | $2,120 | $177 |
| Oxycodone-Acetaminophen | 43 | $1,198 | $28 |
| Oxycontin | 15 | $1,187 | $79 |
| Gabapentin | 32 | $364 | $11 |
| Meloxicam | 59 | $292 | $5 |
| Amoxicillin | 43 | $100 | $2 |
| Tramadol | 15 | $73 | $5 |
2014: 14 drugs
| Celebrex | 114 | $49,534 | $435 |
| Xifaxan | 12 | $15,599 | $1,300 |
| Lyrica | 67 | $15,176 | $227 |
| Oxaprozin | 23 | $4,024 | $175 |
| Oxycontin | 31 | $2,257 | $73 |
| Doxycycline Hyclate | 11 | $2,247 | $204 |
| Oxycodone-Acetaminophen | 76 | $1,659 | $22 |
| Hydrocodone-Acetaminophen | 59 | $863 | $15 |
| Gabapentin | 48 | $520 | $11 |
| Oxycodone | 13 | $236 | $18 |
| Meloxicam | 30 | $169 | $6 |
| Tramadol | 19 | $121 | $6 |
| Naproxen | 12 | $108 | $9 |
| Amoxicillin | 27 | $106 | $4 |
2013: 14 drugs
| Celebrex | 110 | $39,505 | $359 |
| Xifaxan | 13 | $15,416 | $1,186 |
| Lyrica | 57 | $9,289 | $163 |
| Enoxaparin | 11 | $4,295 | $390 |
| Oxycontin | 33 | $2,445 | $74 |
| Doxycycline Hyclate | 13 | $2,405 | $185 |
| Oxaprozin | 12 | $1,569 | $131 |
| Hydrocodone-Acetaminophen | 51 | $775 | $15 |
| Oxycodone-Acetaminophen | 76 | $763 | $10 |
| Gabapentin | 37 | $623 | $17 |
| Diclofenac | 11 | $275 | $25 |
| Meloxicam | 19 | $109 | $6 |
| Naproxen | 12 | $109 | $9 |
| Amoxicillin | 17 | $59 | $3 |
Money from drug and device companies
$12,908 in 2025
| 2025 | 2 | 9 | None | $12,908 |
| 2024 | 1 | 244 | $6,625 | $36,222 |
| 2023 | 3 | 15 | $14,550 | $16,215 |
| 2022 | 3 | 19 | $17,500 | $18,433 |
| 2021 | 2 | 7 | $6,000 | $6,144 |
| 2020 | 1 | 2 | $2,500 | $2,630 |
| 2019 | 3 | 4 | None | $380 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Zimmer Biomet Holdings | Rosa | $12,885 | 8 payments
|
| Vertex Pharmaceuticals | Journavx | $22 | 1 payment
|
See all 9 published payments
| Zimmer Biomet Holdings | Education · 2025-11-20 | None | $3,600 |
| Zimmer Biomet Holdings | Education · 2025-11-13 | Rosa | $3,600 |
| Zimmer Biomet Holdings | Meals · 2025-11-09 | Z1 Hip System | $199 |
| Zimmer Biomet Holdings | Meals · 2025-11-09 | Rosa | $149 |
| Zimmer Biomet Holdings | Education · 2025-07-24 | Rosa | $1,540 |
| Vertex Pharmaceuticals | Meals · 2025-06-25 | Journavx | $22 |
| Zimmer Biomet Holdings | Education · 2025-04-25 | None | $3,600 |
| Zimmer Biomet Holdings | Meals · 2025-04-13 | Rosa | $114 |
| Zimmer Biomet Holdings | Meals · 2025-03-12 | Rosa | $84 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $36,222
| Zimmer Biomet Holdings | Rosa | $36,222 | 48 payments
|
2023: $16,215
| Zimmer Biomet Holdings | Rosa | $16,036 | 13 payments
|
| Djo | Aircast | $157 | 1 payment
|
| Heron Therapeutics | Zynrelef | $22 | 1 payment
|
2022: $18,433
| Zimmer Biomet Holdings | Rosa | $18,303 | 17 payments
|
| Djo | Procare | $118 | 1 payment
|
| Horizon Therapeutics plc | Pennsaid | $13 | 1 payment
|
2021: $6,144
| Zimmer Biomet Holdings | Rosa-Knee | $6,116 | 5 payments
|
| Heron Therapeutics | Zynrelef | $29 | 2 payments
|
2020: $2,630
| Zimmer Biomet Holdings | Persona Revision | $2,630 | 2 payments
|
2019: $380
| Portola Pharmaceuticals | Andexxa | $207 | 2 payments
|
| Zimmer Biomet Holdings | Connected Health Product Portfolio | $148 | 1 payment
|
| ConvaTec | Aquacel Ag | $25 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1093901886
- Licence
- CA A93546, IL 036123296California A93546: Current · expires 2027-10-31Illinois 036123296: Not Renewed
- Trained
- Boston University School of Medicine, 2004
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Orthopedic surgery (207X00000X)
- Mailing address
- 973 University Ave, Los Gatos, CA, 95032
- NPI first listed
- 2007-09-14
- NPI last updated
- 2026-03-10
- NPI record certified
- 2026-03-10
This is when the NPI record was last certified, not a medical board exam.